Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis

Abstract

Findings from this meta-analysis support neurocognitive dysfunction as a potential detection and prognostic biomarker in individuals at CHR-P. These findings may advance clinical research and inform preventive approaches.